Issue: April 2018
March 07, 2018
1 min read
Save

Glaucomatous eyes have higher rate of laser capsulotomy after phaco

Issue: April 2018
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

NEW YORK — When compared with eyes without glaucoma, glaucomatous eyes have a statistically significant higher rate of laser capsulotomy, according to a study presented here.

“We looked at both glaucoma patients and non-glaucoma patients. There is a slightly higher rate of PCO formation in glaucomatous eyes regardless of whether they have a phaco alone vs. a phaco combination procedure with a MIGS procedure. However, glaucomatous eyes had a higher rate of YAG capsulotomy,” study co-author Cara E. Capitena Young, MD, told Healio.com/OSN at the American Glaucoma Society annual meeting.

The retrospective chart review consisted of 3,277 eyes of 2,139 patients who underwent either uncomplicated phaco or phaco-MIGS. The rates of posterior capsule opacification (PCO) and the need for laser capsulotomy were then determined.

Regardless of which procedure was performed, 14.4% of glaucomatous eyes had PCO formation compared with 11.4% of healthy eyes, but the different was not statistically significant.

However, 6.5% of glaucomatous eyes underwent laser capsulotomy compared with 3.3% of non-glaucomatous eyes, which was a statistically significant difference (P = .0034), according to the study.

“Why this is, it is still under investigation, but we have several hypotheses that we’re looking into more,” Young said. by Robert Linnehan

 

Reference:

SooHoo J, et al. Posterior capsulotomy opacification rates following phacoemulsification in glaucomatous and non-glaucomatous eyes. Presented at: American Glaucoma Society annual meeting; Feb. 28 to March 4, 2018; New York.

Disclosure: The researchers report no relevant financial disclosures.